Pioglitazone-induced hepatic injury in a patient previously receiving troglitazone with success [4]

Diabetic Medicine

Volumn 19, Issue 4, 2002, Pages 347-348

  Nagasaka, S ^a   Abe, T ^a   Kawakami, A ^a   Kusaka, I ^a   Nakamura, T ^a   Ishikawa, S ^a   Saito, T ^a   Ishibashi, S ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ALANINE AMINOTRANSFERASE; ALMINOPROFEN; ASPARTATE AMINOTRANSFERASE; CALCIUM; DILTIAZEM; DOXAZOSIN; GLIBENCLAMIDE; GLICLAZIDE; HEMOGLOBIN A1C; LACTATE DEHYDROGENASE; PIOGLITAZONE; SIMVASTATIN; SULFONYLUREA; THIAZOLIDINE DERIVATIVE; TROGLITAZONE; VITAMIN D;

ADULT; ANAMNESIS; ANTIHYPERTENSIVE THERAPY; BLOOD ANALYSIS; BODY MASS; CASE REPORT; CLINICAL FEATURE; DIABETES CONTROL; DIET THERAPY; DRUG WITHDRAWAL; FEMALE; HOMEOSTASIS; HUMAN; HYPERTENSION; INSULIN RESISTANCE; KINESIOTHERAPY; LETTER; LIVER INJURY; NON INSULIN DEPENDENT DIABETES MELLITUS; PAIN; PRESCRIPTION; TREATMENT FAILURE;

CHROMANS; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; FEMALE; GLYBURIDE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; LIVER; MIDDLE AGED; THIAZOLES; THIAZOLIDINEDIONES;

EID: 0036272050     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2002.00712_4.x     Document Type: Letter

References (6)

1. Thiazolidinediones in the treatment of insulin resistance and type II diabetes
2. Efficacy of troglitazone measured by insulin resistance index
3. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man
4. Failure to develop hepatic injury from rosiglitazone in a patient with a history of troglitazone-induced hepatitis
5. Hepatic failure in a patient taking rosiglitazone
6. Hepatocellular injury in a patient receiving rosiglitazone. A case report